Colistimethate injection is an antibiotic medication used for the treatment of severe or life-threatening infections caused by certain types of bacteria. It is commonly used to treat infections caused by multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. These types of infections may occur in people who have weakened immune systems, burn wounds, or cystic fibrosis. Colistimethate injection works by interfering with the growth and reproduction of the bacteria, helping to clear the infection and prevent it from spreading.
Colistimethate sodium injection 150 mg per vial is a medication used to treat respiratory tract infections caused by certain bacteria, including Pseudomonas aeruginosa and Acinetobacter baumannii. It belongs to a class of drugs called polymyxins, which work by disrupting the integrity of the bacterial cell membrane, leading to cell death. This injection is usually administered intravenously or intramuscularly by a healthcare professional. It is available in vials containing 150 mg of colistimethate sodium powder for reconstitution.
Colistimethate Sodium Injection 150 mg Per Vial by Avet Pharmaceuticals
Benefits of Colistimethate Sodium Injection 150 mg per vial include its ability to treat serious bacterial infections, particularly those caused by multi-drug resistant organisms. It is also considered to have a relatively low toxicity profile and can be administered via intravenous or intramuscular injection, providing flexibility in treatment options. Additionally, its long-acting formulation means that it only needs to be administered once or twice daily, reducing the burden on patients and healthcare providers. Overall, Colistimethate Sodium Injection 150 mg per vial may provide a viable treatment option for infections that are resistant to other antibiotics.Â
Skip to content
